FLT3-ligand administration inhibits liver metastases: role of NK cells.

MLA

Péron, J. M., et al. “FLT3-Ligand Administration Inhibits Liver Metastases: Role of NK Cells.” Journal of Immunology (Baltimore, Md. : 1950), vol. 161, no. 11, Dec. 1998, pp. 6164–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9834102&authtype=sso&custid=ns315887.

APA

Péron, J. M., Esche, C., Subbotin, V. M., Maliszewski, C., Lotze, M. T., & Shurin, M. R. (1998). FLT3-ligand administration inhibits liver metastases: role of NK cells. Journal of Immunology (Baltimore, Md. : 1950), 161(11), 6164–6170.

Chicago

Péron, J M, C Esche, V M Subbotin, C Maliszewski, M T Lotze, and M R Shurin. 1998. “FLT3-Ligand Administration Inhibits Liver Metastases: Role of NK Cells.” Journal of Immunology (Baltimore, Md. : 1950) 161 (11): 6164–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9834102&authtype=sso&custid=ns315887.